Position Description: Title: Senior Counsel (SC) Location: New York, NY Reports to: General Counsel Position Summary:
The Senior Counsel (SC) will provide legal support to IAVI’s Research and Development (R&D) programs, which include a wide range of vaccine and antibody discovery and/or development programs and projects, both internally generated or externally partnered, with academic and industry collaborators. The SC will provide legal advice and input to the R&D team, working closely with the project teams and providing proactive leadership in the identification and resolution of legal issues, and the structuring and negotiation of a diverse range of R&D related agreements and collaborative activities. The position will also provide legal support to IAVI’s research laboratory network in NYC, La Jolla California, London and Delhi, and clinical development programs. The SC will also work closely with IAVI’s Business Development group to coordinate business development and intellectual property support, as may be needed, for IAVI R&D programs.
Key Responsibilities: • Provide legal support to IAVI’s R&D programs, including interactions with research laboratories, pre-clinical and clinical translational development activities (e.g., CDAs, MTAs, research agreements, clinical trial agreements, collaboration agreements, license agreements, etc.), the establishment of vaccine development collaborations, and provide support to regulatory and quality activities and functions; • Draft, review and negotiate contracts with partner organizations (pharma and biotech companies, universities, NGOs and governments), and provide business focused legal advice; • Work in a coordinated and integrated fashion within IAVI’s General Counsel’s Office, and with the Business Development and intellectual property management functions, to support IAVI’s R&D programs; • Work with R&D team in ensuring the success of the business and in the support of its translational development activities; and • Manage multiple projects independently.
Education, Experience and Skills: • JD degree and New York bar admission; • Minimum 6+ years relevant work experience; • Commercial/transactional experience, including contracts and intellectual property issues relating to pre-clinical and clinical research activities and business development activities; • Strong experience with pharma, biotech and/or academic life science research and development, with experience in vaccine or antibody based research and translational development preferred; • Familiarity with intellectual property issues arising from pharma sector and/or vaccine product development; • Ability to manage complex issues; • Proactive, action oriented, and collaborative; • Strong project management skills; • Excellent verbal and written communications skills; • Strong negotiation and drafting skills; and • Strong analytical skills.
Leadership and Communication
• Receptive to and takes positive action on feedback, recommendations and requests; • Listens actively and communicates effectively with others; • Clearly articulates viewpoints and respects others’ ideas; • Takes proactive steps to collaborate with members from other teams/departments; • Strives for excellence and seeks solutions to system/process failures; and • Fulfills commitments; and is accountable for outcomes.
About International AIDS Vaccine Initiative (IAVI)
IAVI Core Values:
Dedication to the Mission: We are committed to the development of safe, effective, accessible, preventive HIV vaccines for use throughout the world to achieve a world without AIDS
Innovative Evolution: We are committed to solving complex problems in creative and innovative ways, learning from our mistakes and successes and never giving up
Integrity: We are committed to meeting the highest ethical and professional standards in everything we do and to taking responsibility for our actions to earn respect
Collaboration: We are committed to embracing diversity, the power of glocal teamwork and the belief that by working as one we can make a difference
The International AIDS Vaccine Initiative (IAVI) is a nonprofit scientific organization whose mission is to develop vaccines and other biomedical innovations that prevent HIV infection. Since its founding in 1996, IAVI has provided scientific, research and development, and policy leadership to address the needs of communities and key populations at risk for HIV infection around the world. IAVI works with more than 100 academic, industry, government, civil society, clinical, and community ...partners in more than 25 countries. IAVI is committed to supporting the broad field of HIV vaccine research and to fostering collaborations that accelerate the development and availability of new prevention tools. In pursuit of our goals, we work to catalyze and support novel partnership models that engage partners from both the public and private sectors across the product development continuum.
IAVI’s global reach, including its clinical research network in five countries in sub-Saharan Africa and in India, has allowed IAVI to make fundamental contributions to understanding of the epidemiology, transmission, natural history, virology, and immunology of HIV infection. This work played a key role in facilitating the structure-based design of promising HIV vaccine candidates as well as the discovery of “broadly neutralizing antibodies” that are now being advanced as promising approaches for HIV prevention. IAVI’s integrated capabilities in vaccine discovery, development, and clinical research take advantage of biopharmaceutical industry expertise to accelerate the development and testing of novel HIV vaccine candidates.
In addition to its core HIV vaccine effort, IAVI is working to amplify its global health impact by working with partners to address other urgent unmet public health needs – such as vaccines for other infectious diseases (e.g., Tuberculosis, other emerging infectious diseases, such as Lassa Fever Virus, etc.) or other global health challenges, where our existing technologies, assets, and experience can add unique value.